A large investment of at least US$3.9 billion needed to meet the World Health Organization’s (WHO) target for the elimination of Hepatitis C virus (HCV) in Pakistan could deliver huge benefits in terms of lives saved and reduced ill health, according to University of Bristol led research published in The Lancet Global Health. Pakistan has one…
Category: Research
Research: Improvements in screening, prevention and treatment required to meet global hep C elimination targets
New research published in The Lancet suggests that if improvements in public health interventions for hepatitis C are made, the global elimination targets of reducing new infections by 80% could be met in 2030, and the target to reduce mortality by 65% could be met in 2032. The study modelled the impact of four public…
Research: Needle/syringe programs highly cost-effective for hep C prevention in UK
According to research published in Addiction, needle and syringe programs are a highly cost-effective means of preventing hepatitis C transmission among people who inject drugs. Investment in such programming, the results show, could save millions of pounds in treatment costs in the United Kingdom (UK). Using data from three UK cities, the researchers estimated the…
Research: Modelling for microelimination in 3 regions of Switzerland
New research published in Swiss Medical Weekly models the current epidemiology of hepatitis C virus in three regions of Switzerland, identifying increases in diagnosis and treatment rates that may be required to achieve the goals of the Swiss Hepatitis Strategy. According to the study, elimination of chronic hepatitis C infection in eastern (region of St…
Microelimination.org: resources for individuals and organizations interested in hepatitis C microelimination 